1. |
Yan, HT, Tang LJ, Chen T, et al.Defining and predicting complete remission of type 2 diabetes:a short-term efficacy study of open gastric bypass.Obesity Facts, 2013, 6(2):176-184.
|
2. |
Agrawal V, Khan I, Rai B, et al.The effect of weight loss after bariatric surgery on albuminuria.Clin Nephrol, 2008, 70(3):194-202.
|
3. |
Saliba J, Kasim NR, Tamboli RA, et al.Roux-en-Y gastric bypass reverses renal glomerular but not tubular abnormalities in excessively obese diabetics.Surgery, 2010, 147(2):282-287.
|
4. |
Srinivasan K, Viswanad B, Asrat L, et al.Combination of high-fat diet-fed and low-dose streptozotocin-treated rat:a model for type 2 diabetes and pharmacological screening.Pharmacol Res, 2005, 52(4):313-320.
|
5. |
文敏, 周波, 余资江.免疫组织化学图像光度学参数的选择及测量.局解手术学杂志, 2009, 18(6):377-378.
|
6. |
Magee GM, Bilous RW, Cardwell CR, et al.Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis.Diabetologia, 2009, 52(4):691-697.
|
7. |
廉永昕, 张嘉莉, 李兢.糖尿病肾病发病机制研究进展.中国疗养医学, 2012, 12(6):515-516.
|
8. |
Fowler SM, Kon V, Ma L, et al.Obesity-related focal and segmental glomerulosclerosis:normalization of proteinuria in an adolescent after bariatric surgery.Pediatr Nephrol, 2009, 24(4):851-855.
|
9. |
Alexander JW, Goodman HR, Hawver LR, et al.Improvement and stabilization of chronic kidney disease after gastric bypass.Surg Obes Relat Dis, 2009, 5(2):237-241.
|
10. |
Lan HY.Diverse roles of TGF-β/Smads in renal fibrosis and inflam-mation.Int J Biol Sci, 2011, 7(7):1056-1067.
|
11. |
Sotkes MB, Holler S, Cui Y, et al.Expression of decorin, biglyein, and collgane typeⅠin human renal fibrosis disease.Kidney Int, 2000, 57(2):487-498.
|
12. |
Petersen M, Thorikay M, Deckers M, et al.Oral administration of GW788388, an inhibitor of TGF-beta typeⅠandⅡreceptor kinases, decreases renal fibrosis.Kidney Int, 2008, 73(6):705-715.
|
13. |
Valladares-Salgado A, Angeles-Martlnez J, Rosas M, et al.Association of polymorphisms within the transforming growth factor-β1 with diabetic nephmpathy and serum cholesterol and triglyceride concentrations.Nephrology, 2010, 15(6):644-648.
|
14. |
Shiose A, Kuroda J, Tsuruya K, et al.A novel superoxide-producing NAD(P)H oxidase in kidney.J Biol Chem, 2001, 276(2):1417-1423.
|
15. |
Gorin Y, Block K, Hernandez J, et al.Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney.J Biol Chem, 2005, 280(47):39616-39626.
|
16. |
Sharma K, Ramachandrarao S, Qiu G, et al.Adiponectin regulates albuminuria and podocyte function in mice.J Clin Invest, 2008, 118(5):1645-1656.
|
17. |
Etoh T, Inoguchi T, Kakimoto M, et al.Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment.Diabetologia, 2003, 46(10):1428-1437.
|
18. |
Liu G, Sun Y, Li Z, et al.Apoptosis induced by endoplasmic reticulum stress involved in diabetic kidney disease.Biochem Biophys Res Commun, 2008, 370(4):651-656.
|
19. |
Reed JC, Zha H, Aime-Sempe C, et al.Structure-function analysis of Bcl-2 family proteins.Regulators of programmed cell death.Adv Exp Med Biol, 1996, 406:99-112.
|
20. |
Ortiz A, Ziyadeh FN, Neilson EG.Expression of apoptosis-regulatory genes in renal proximal tubular epith elial cells exposed to high ambient glucose and in diabetic kidneys.J Investig Med, 1997, 45(2):50-56.
|
21. |
Dal Canton A, Fuiano G, Sepe V, et al.Mesangial expression of intercellular adhesion molecule-1 in primary glomerulosclerosis.Kidney Int, 1992, 41(4):951-955.
|
22. |
Sugimoto H, Shikata K, Hirata K, et al.Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli:glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation.Diabetes, 1997, 46(12):2075-2081.
|